Association of progression-free survival with patient-reported outcomes and survival: results from a randomised phase 3 trial of panitumumab
2007 · British Journal of Cancer · 85 citations
https://doi.org/10.1038/sj.bjc.6604053
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
54
Papers
630
Citations
12
h-index
14
i10-index
Danila Comandini is an academic researcher from Ospedale Policlinico San Martino. The author has contributed to research in topics: Sarcoma Diagnosis and Treatment & Gastrointestinal Tumor Research and Treatment & Breast Cancer Treatment Studies. The author has an h-index of 12, co-authored 46 publications.
ORCID: 0000-0003-3465-120Xhttps://doi.org/10.1038/sj.bjc.6604053
https://doi.org/10.1186/s12967-024-05227-2
Click to start Chat